Fred Lublin, MD
- PROFESSOR | Neurology
Fred D. Lublin, M.D. is the Saunders Family Professor of Neurology at The Icahn School of Medicine at Mount Sinai and Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at that institution.
Dr. Lublin received his medical degree in 1972 from Jefferson Medical College, Philadelphia, PA. He completed his internship in Internal Medicine from the Bronx Municipal Hospital, Albert Einstein Medical Center, and his neurology residency at the New York Hospital, Cornell Medical Center.
As a neuroimmunologist, Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system. He has been involved in both basic science and clinical research. He and his colleagues were among the first in the country involved with studies of Interferon beta-1b, which was approved by the Food & Drug Administration in 1993 to treat the relapsing-remitting form of Multiple Sclerosis. He has since been involved in the development of nearly all of the currently available agents to treat MS. At present, He is involved with several new clinical research protocols on promising agents for treating various aspects of MS. He was chairman of the National MS Society (USA) advisory committee on clinical trials of new drugs in Multiple Sclerosis and the National Multiple Sclerosis Society’s Research Programs Advisory Committee. He was a member of the National MS Society National Board of Directors. He is past Chair of the New York City/Southern New York Chapter of NMSS Clinical Advisory Committee. He was a member of the International Medical & Scientific Board of the Multiple Sclerosis International Federation. Dr. Lublin and his colleagues at the National MS Society have re-defined the clinical course definitions of MS, updated in 2014. He has chaired a task force on the ethics of placebo-controlled trials in MS. Dr. Lublin is a member of the international panel that periodically redefines the diagnostic criteria for MS (McDonald Criteria). Dr. Lublin is co-chair of the National Institute of Neurological Diseases and Stroke MS Common Data Element committee and a member of their steering committee. He was a Co-Chief and founding Editor of the journal Multiple Sclerosis and Related Disorders.
Dr. Lublin has published numerous scientific articles and is a member of many professional societies and advisory boards. Dr. Lublin has served as a consultant to the National Institutes of Health and to many pharmaceutical/biotech companies in all phases of new drug development and in preparation for presentation to the FDA and their advisory panels. He was the Principal Investigator of the NIH-sponsored multicenter Combination Therapy study in Multiple Sclerosis. Dr. Lublin has received the June Halper Lifetime Achievement Award from the Consortium of Multiple Sclerosis Centers and the Hope Award from the National MS Society.
For more information aboutclinical trials, please call Dr. Lublin's office.
Dr. Lublin offers telemedicine appointments when appropriate. Please call his office to schedule a video visit.
Dr. Lublin is registered to provide telehealth services in Florida.
American Board of Psychiatry and Neurology
- Multiple Sclerosis
- Neuromyelitis optica
MD, Jefferson Medical College
Internship, Internal Medicine, Albert Einstein College of Medicine-Yeshiva University
Residency, Neurology, Weill Medical College of Cornell University
Award for Recognition of Leadership and Dedication in Applying Medical Education to Improve Care of Patients with Multiple Sclerosis
June Halpern Lifetime Achievement Award
Clifford Goldsmith Award
Honorary Member of the French Society of Neurology
Award of Appreciation for Outstanding Academic Teaching
Attending of the Year Award
Chairman, Research Programs Advisory Committee
McEwan Visiting Professorship & Lecture in Neurology
Clinical trials in MS and other demyelination disorders
Basic and translational neuroimmunology
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lublin during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Actelion/Janssen; Baim Institute; Banner Life Sciences; Biogen Idec; Bristows; Burns White; Clayton Utz; DLA Piper LLP; EMD Serono, Inc. (Merck & Co., Inc.); Excite International; Furman Kornfeld & Brennan LLP; GW Pharma; Gerspach Sikoscow LLP; Gibson Dunn; Hall Booth Smith & Slover, P.C.; Heidell, Pittoni, Murphy & Bach, LLP; Jazz Pharmaceuticals; Kaufman Borgeest & Ryan LLP; Novartis; Rawle & Henderson; Ryan Ryan Deluca LLP; Sanofi/Genzyme; Sudo Bioscience; Teva Pharmaceutical Industries Ltd.; The Population Council
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Avotres; Neuralight
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- EMD Serono, Inc. (Merck & Co., Inc.); F. Hoffman-La Roche Ltd.; Sanofi/Genzyme
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.